Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
News
Overview
Regulatory News
Overview
Regulatory News
Home
UK Shares
UK SHARES
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
MARKET DATA
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
FUNDS
Funds Centre
Managers
News
Brokers
BROKERS
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
SPREAD BET
Learn
Strategies
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist
Sector
Pharma and Biotech
Indices
FTSE 100
FTSE-350
FTSE All-Share
AstraZeneca (AZN)
12,018.00p
17:15 27/02/25
1.14%
136.00p
Today's Low & High
11,764.00
/
12,048.00
Open / Previous Close
11,764.00 / 12,018.00
52-week range
16.36%
1,690.00p
Volume
4,126,540
Market Cap(billion)
£186.35b
Advertising
News
Overview
Regulatory News
Latest webfg news
AstraZeneca's camizestrant shows promise in breast cancer trial
26 Feb
London close: Stocks slip as US jobless claims rise
20 Feb
UBS ups rating on AstraZeneca to 'buy'
13 Feb
Morgan Stanley sees huge upside at AstraZeneca
12 Feb
Revenues, profits surge at AstraZeneca
06 Feb
AstraZeneca's Imfinzi set for go-ahead by EU to treat lung cancer
03 Feb
AstraZeneca's Enhertu gets new US approval
30 Jan
AstraZeneca gets first US approval for cancer treatment Datroway
20 Jan
AstraZeneca's rare cancer drug Calquence gets US regulatory nod
17 Jan
London close: Stocks mixed in quiet post-Christmas trade
27 Dec
AstraZeneca pulls EU application for cancer drug
24 Dec
AstraZeneca lung cancer drug Tagrisso approved by EU regulators
23 Dec
AstraZeneca cancer drug secures US approval
05 Dec
AstraZeneca appoints Iskra Reic as vice-president of intl unit
04 Dec
AstraZeneca reports positive results from prostate cancer trial
25 Nov
AstraZeneca's Tagrisso recommended for EU approval
18 Nov
Sunday newspaper round-up: Kursk, AstraZeneca, BAE Systems
17 Nov
London close: Stocks end turbulent week in the red
15 Nov
Director dealings: AstraZeneca CEO ups stake
15 Nov
London close: Stocks sink as UK jobless rate rises
12 Nov
«
2024-10
2024-11
2024-12
2025-01
2025-02
Loading:
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In